嘉應制藥(002198.SZ)取得《藥品GMP證書》
格隆匯11月29日丨嘉應制藥(002198.SZ)公佈,公司梅州本部生產車間今年10月份接受了廣東省藥品監督管理局GMP驗收,近日收到了廣東省藥品監督管理局頒發的中華人民共和國《藥品GMP證書》。經審查,公司符合中華人民共和國《藥品生產質量管理規範》的要求,認證範圍:片劑、硬膠囊劑、顆粒劑、丸劑(蜜丸、水蜜丸)、散劑、中藥前處理和提取車間(口服制劑);有效期至:2024年11月18日。
根據今年董事會制定的工作計劃,以梅州生產基地原《藥品GMP證書》到期後生產車間重新認證為契機,公司於2019年7月至9月啟動了對生產車間GMP改造及散劑生產設備自動化升級改造。項目現已改造完成並順利通過藥監、消防等部門的驗收,生產效率得到進一步提高,達到了“減員增效”的目的。
此次生產車間是在生產設備更新升級後的基礎上取得GMP認證,確保了公司生產車間能夠持續高效地提供高質量產品,滿足市場需求,進一步保障公司以優質產品服務於市場,對公司未來穩健發展有着積極的推動作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.